Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Meerpohl

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with plantinumA du Bois, H J Lück, K Buser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinomaH Hebart, C Erley, B Kaskas, et al.
Seminars in Oncology|February 1, 1997
Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer: a phase I trialH G Meerpohl, A du Bois, H J Luck, et al.
Seminars in Oncology|December 1, 1995
Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancerH G Meerpohl, A du Bois, H Kühnle, et al.
Seminars in Oncology|January 14, 1998
Phase I study of paclitaxel administered as a 1-hour infusion: toxicity and pharmacokineticsH Maier-Lenz, B Hauns, B Haering, et al.
Seminars in Oncology|February 1, 1996
Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancerH J Luck, C Thomssen, A duBois, et al.
Seminars in Oncology|February 1, 1997
Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancerH J Lück, C Thomssen, A du Bois, et al.
Oncology (Williston Park, N.Y.)|February 3, 2005
Anthracycline and trastuzumab in breast cancer treatmentM Untch, I Himsl, S Kahlert, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2004
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trialM Untch, H Eidtmann, A du Bois, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with plantinumA du Bois, H J Lück, K Buser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinomaH Hebart, C Erley, B Kaskas, et al.
Seminars in Oncology|February 1, 1997
Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer: a phase I trialH G Meerpohl, A du Bois, H J Luck, et al.
Seminars in Oncology|December 1, 1995
Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancerH G Meerpohl, A du Bois, H Kühnle, et al.
Seminars in Oncology|January 14, 1998
Phase I study of paclitaxel administered as a 1-hour infusion: toxicity and pharmacokineticsH Maier-Lenz, B Hauns, B Haering, et al.
Seminars in Oncology|February 1, 1996
Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancerH J Luck, C Thomssen, A duBois, et al.
Seminars in Oncology|February 1, 1997
Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancerH J Lück, C Thomssen, A du Bois, et al.
Oncology (Williston Park, N.Y.)|February 3, 2005
Anthracycline and trastuzumab in breast cancer treatmentM Untch, I Himsl, S Kahlert, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2004
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trialM Untch, H Eidtmann, A du Bois, et al.
Pageof 4